HIGHFDA DEVICE

Beckman Coulter Recalls LDL Cholesterol Assay Due to Performance Issues

Beckman Coulter recalled 34,451 units of its LDL Cholesterol OSR6x96 assay on December 8, 2025, due to significant performance interference. The recall affects multiple states in the U.S. and several countries internationally. Affected products may provide inaccurate LDL cholesterol readings, posing health risks to patients.

Official notice
Beckman Coulter IrelandHealth & Personal CareMedical DevicesREF/UDI-DI: OSR6196/15099590010928OSR6296/15099590020361. All Lots and Expiration Dates. IFU Version BAOSR6X96-10 and prior.

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DEVICE
Recall date
December 8, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
December 8, 2025
Hazard Level
HIGH
Brand
Beckman Coulter Ireland
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
Nationwide (50 states)
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Medical Devices; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Beckman Coulter Ireland
Product type
LDL Cholesterol Assay
Model numbers
REF/UDI-DI: OSR6196/15099590010928, OSR6296/15099590020361. All Lots and Expiration Dates. IFU Version BAOSR6X96-10 and prior.
Sold at
Multiple Retailers
Where affected
Nationwide

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    December 8, 2025

  2. Reported by FDA DEVICE

    January 28, 2026

  3. RecallRadar source check

    February 4, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Beckman Coulter identified that LDL Cholesterol OSR6x96 is not meeting the performance claim listed in the Instructions for Use (IFU). LDL Cholesterol reagent showed clinically significant interference due to triglyceride concentration up to 1500 mg/dL may cause a maximum positive bias of up to 28.8% in low LDL Cholesterol samples (concentration 80 mg/dL) and up to 11.02% in high LDL Cholesterol samples (concentration 160mg/dL).

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Beckman Coulter Ireland, Inc. or your healthcare provider for instructions. Notification method: Letter

About This Product

The LDL Cholesterol OSR6x96 assay is used to measure cholesterol levels in patients, particularly LDL cholesterol, which is a key factor in assessing cardiovascular health. Healthcare providers rely on accurate measurements for diagnosing and managing patients with dyslipidemia.

Why This Is Dangerous

This assay may inaccurately measure LDL cholesterol due to significant interference from high triglyceride levels, leading to potentially misleading results. This can result in either overestimating or underestimating a patient's cholesterol levels, impacting treatment decisions.

Industry Context

This recall is not part of a broader industry pattern.

Real-World Impact

Patients could face serious health risks due to inaccurate cholesterol readings, leading to inappropriate medical decisions. The recall may also cause inconvenience for healthcare providers needing to find reliable alternatives.

Practical Guidance

How to identify if yours is affected

  1. Verify the model number against REF/UDI-DI: OSR6196/15099590010928 or OSR6296/15099590020361.
  2. Check for any communication from Beckman Coulter regarding this recall.
  3. Consult your healthcare provider for further confirmation.

Where to find product info

Model numbers can typically be found on the packaging or the assay box.

What timeline to expect

Expect a refund processing time of about 4 to 6 weeks after returning the product.

If the manufacturer is unresponsive

  • Reach out to Beckman Coulter Ireland directly for assistance.
  • Consider contacting the FDA or regulatory bodies for further guidance.

How to prevent similar issues

  • Always verify the performance claims of medical devices before purchase.
  • Look for products with established safety records and reliable certification.
  • Stay informed about product recalls and safety notifications.

Documentation advice

Document any correspondence with Beckman Coulter and keep records of your purchase and communications regarding the recall.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

The recalled product is the LDL Cholesterol OSR6x96 assay, identified by model numbers REF/UDI-DI: OSR6196/15099590010928 and OSR6296/15099590020361. The assay was distributed in the U.S. and internationally, including countries like Brazil and Germany. All lots and expiration dates are affected.

Key Facts

  • Recalls 34,451 units of LDL Cholesterol OSR6x96 assay
  • Potential bias in cholesterol readings up to 28.8%
  • Distributed in multiple U.S. states and internationally
  • Immediate cessation of use is advised

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product TypeLDL Cholesterol Assay
Sold At
Multiple Retailers

Product Details

Model Numbers
REF/UDI-DI: OSR6196/15099590010928
OSR6296/15099590020361. All Lots and Expiration Dates. IFU Version BAOSR6X96-10 and prior.
Affected States
Nationwide
Report Date
January 28, 2026
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

Taro Pharmaceuticals Withdraws Diclofenac Sodium Gel Over Viscosity Issues

Taro Pharmaceuticals announced a market withdrawal of Diclofenac Sodium, Topical Gel, 3% on January 27, 2026. The withdrawal stems from out of specification viscosity results. Healthcare providers and consumers should stop using the product immediately.

BEEKEEPER'S NATURALS USA
Microbial Contamination
Read more
Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more